New horizons in the treatment and management of Lymphoma: Novel therapies for improved patient outcomes
Publication
, Journal Article
McKinney, MS
Published in: Journal of Managed Care Medicine
January 1, 2019
The treatment of lymphoma continues to evolve with a better understanding of the genetics, cell markers, and tumor microenvironment which all play a role in the growth and proliferation of the disease. Several targeted and immunotherapies are now available and are improving outcomes in both follicular and Hodgkin lymphoma.
Duke Scholars
Published In
Journal of Managed Care Medicine
ISSN
1094-1525
Publication Date
January 1, 2019
Volume
22
Issue
2
Start / End Page
73 / 78
Citation
APA
Chicago
ICMJE
MLA
NLM
McKinney, M. S. (2019). New horizons in the treatment and management of Lymphoma: Novel therapies for improved patient outcomes. Journal of Managed Care Medicine, 22(2), 73–78.
McKinney, M. S. “New horizons in the treatment and management of Lymphoma: Novel therapies for improved patient outcomes.” Journal of Managed Care Medicine 22, no. 2 (January 1, 2019): 73–78.
McKinney MS. New horizons in the treatment and management of Lymphoma: Novel therapies for improved patient outcomes. Journal of Managed Care Medicine. 2019 Jan 1;22(2):73–8.
McKinney, M. S. “New horizons in the treatment and management of Lymphoma: Novel therapies for improved patient outcomes.” Journal of Managed Care Medicine, vol. 22, no. 2, Jan. 2019, pp. 73–78.
McKinney MS. New horizons in the treatment and management of Lymphoma: Novel therapies for improved patient outcomes. Journal of Managed Care Medicine. 2019 Jan 1;22(2):73–78.
Published In
Journal of Managed Care Medicine
ISSN
1094-1525
Publication Date
January 1, 2019
Volume
22
Issue
2
Start / End Page
73 / 78